Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The BCL2 associated athanogene 4 pseudogene (ENSG00000255107) is a non-functional sequence in the human genome related to the BAG4 gene, also known as silencer of death domains (SODD). Unlike the functional BAG4 gene—which encodes a protein involved in apoptosis regulation, chaperone activity, and potentially in cancer progression—the pseudogene does not produce a functional protein and is not implicated as a therapeutic target or biomarker. BAG4 itself is involved in inhibiting apoptosis and regulating stress responses, but these functions do not apply to its pseudogene variant. The *functional* gene/protein of interest is "BCL2 associated athanogene 4 (BAG4, SODD)", which *is* implicated in apoptosis, cell proliferation, and cancer, but ENSG00000255107 specifically refers to a non-coding, non-target pseudogene. Pseudogenes like ENSG00000255107 do not encode active proteins, have no established drug interactions, and are not considered direct therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 associated athanogene 4 pseudogene (null).